How Five Sponsors And Cros Are Winning In The GLP-1 Race

As cardiometabolic research grows increasingly competitive, trial teams face mounting pressure to accelerate study startup, scale across expanding portfolios, and maintain high participant engagement. This collection of real-world outcomes highlights how digital trial technologies can help sponsors and CROs address these challenges while improving operational efficiency and data quality.

From reducing study startup timelines by more than 50% to screening over 1,000 patients and enrolling 700 participants in less than six weeks, the results demonstrate the impact of streamlined workflows, standardized processes, and patient-centric design. Across global diabetes and weight management programs, organizations achieved participant compliance rates exceeding 90%, supported rapid portfolio expansion, and accelerated study closeout activities. The insights showcase practical strategies for improving consistency across studies, enhancing site and participant experiences, and turning complex trial operations into scalable, repeatable processes.

Explore the full asset to see how leading organizations are using technology to move faster, support better patient adherence, and advance cardiometabolic programs with greater confidence.